HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Online-Only Appendix Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Tan, K. Articles by Barroso, I. Search for Related Content PubMed PubMed Citation Articles by Tan, K. Articles by Barroso, I. Social Bookmarking                What's this?

Analysis of Genetic Variation in Akt2/PKB-ß in Severe Insulin Resistance, Lipodystrophy, Type 2 Diabetes, and Related Metabolic Phenotypes

¹ Department of Clinical Biochemistry, University of Cambridge, Cambridge, U.K
² Metabolic Disease Group, The Wellcome Trust Sanger Institute, Cambridge, U.K
³ Medical Research Council Epidemiology Unit, Cambridge, U.K

Address correspondence and reprint requests to Dr. Inês Barroso, Metabolic Disease Group, Wellcome Trust Sanger Institute, The Wellcome Trust Genome Campus, Hinxton, Cambridgeshire, CB10 1SA, U.K. E-mail: ib1{at}sanger.ac.uk

Abbreviations: CCC, Cambridgeshire Case Control; EPIC, European Prospective Investigation into Cancer and Nutrition; HWE, Hardy-Weinberg equilibrium; MAF, minor allele frequency; MRC, Medical Research Council; SIR, severe insulin resistant; SNP, single nucleotide polymorphism

We previously reported a family in which a heterozygous missense mutation in Akt2 led to a dominantly inherited syndrome of insulin-resistant diabetes and partial lipodystrophy. To determine whether genetic variation in AKT2 plays a broader role in human metabolic disease, we sequenced the entire coding region and splice junctions of AKT2 in 94 unrelated patients with severe insulin resistance, 35 of whom had partial lipodystrophy. Two rare missense mutations (R208K and R467W) were identified in single individuals. However, insulin-stimulated kinase activities of these variants were indistinguishable from wild type. In two large case-control studies (total number of participants 2,200), 0 of 11 common single nucleotide polymorphism (SNPs) in AKT2 showed significant association with type 2 diabetes. In a quantitative trait study of 1,721 extensively phenotyped individuals from the U.K., no association was found with any relevant intermediate metabolic trait. In summary, although heterozygous loss-of- function mutations in AKT2 can cause a syndrome of severe insulin resistance and lipodystrophy in humans, such mutations are uncommon causes of these syndromes. Furthermore, genetic variation in and around the AKT2 locus is unlikely to contribute significantly to the risk of type 2 diabetes or related intermediate metabolic traits in U.K. populations.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?